{"id":"citalopram-ssri","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Nausea"},{"rate":"10-15","effect":"Headache"},{"rate":"10-15","effect":"Insomnia"},{"rate":"10-15","effect":"Somnolence"},{"rate":"10-15","effect":"Sexual dysfunction"},{"rate":"5-10","effect":"Dry mouth"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"5-10","effect":"Tremor"}]},"_chembl":{"chemblId":"CHEMBL1200781","moleculeType":"Small molecule","molecularWeight":"405.31"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Citalopram blocks the serotonin transporter (SERT), preventing the reabsorption of serotonin from the synaptic cleft back into presynaptic neurons. This increases serotonin concentration in the synapse, enhancing neurotransmission and improving mood regulation. It has minimal effects on other neurotransmitter systems compared to older antidepressants.","oneSentence":"Citalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:02.430Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Panic disorder"},{"name":"Obsessive-compulsive disorder (off-label)"}]},"trialDetails":[{"nctId":"NCT07478796","phase":"PHASE4","title":"TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2025-04-03","conditions":"Depression - Major Depressive Disorder, Depressive Episodes","enrollment":180},{"nctId":"NCT04497168","phase":"PHASE2","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-04-01","conditions":"Parkinson Disease","enrollment":58},{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":"Major Depressive Disorder (MDD)","enrollment":30},{"nctId":"NCT07432815","phase":"PHASE4","title":"Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-02-01","conditions":"Depression, Anxiety, Psoriasis","enrollment":40},{"nctId":"NCT06049797","phase":"","title":"A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2023-11-15","conditions":"Hot Flashes","enrollment":999},{"nctId":"NCT07399795","phase":"","title":"Citalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":7110},{"nctId":"NCT07274241","phase":"","title":"Escitalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":12145},{"nctId":"NCT06216535","phase":"PHASE2","title":"Escitalopram in Asthma Patients With Frequent Exacerbation","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-05-19","conditions":"Asthma","enrollment":105},{"nctId":"NCT06937476","phase":"NA","title":"Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-05-08","conditions":"Major Depressive Disorder (MDD), Rumination","enrollment":108},{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":46},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT06965569","phase":"PHASE1","title":"Multiple Ascending Dose Phase 1 Study of ALA-3000","status":"COMPLETED","sponsor":"Alar Pharmaceuticals Inc.","startDate":"2025-04-21","conditions":"Treatment Resistant Depression","enrollment":37},{"nctId":"NCT05944926","phase":"PHASE3","title":"Improving Outcomes in Depression in Primary Care in a Low Resource Setting","status":"RECRUITING","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2024-03-18","conditions":"Depression, Depressive Disorder","enrollment":1500},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":"Major Depressive Disorder","enrollment":228},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT06001021","phase":"NA","title":"Cognitive Behavioral Couple Therapy for Perinatal Distress","status":"COMPLETED","sponsor":"Sameera Shafiq","startDate":"2023-08-15","conditions":"Perinatal Depression, Perinatal Anxiety","enrollment":96},{"nctId":"NCT07120880","phase":"PHASE3","title":"Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Major Depressive Disorder (MDD) With Insomnia","enrollment":184},{"nctId":"NCT07074652","phase":"NA","title":"The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry","status":"COMPLETED","sponsor":"UCLH/UCL Joint Research Office","startDate":"2017-12-01","conditions":"Anxiety","enrollment":145},{"nctId":"NCT04410341","phase":"PHASE1, PHASE2","title":"The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2020-05-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT05830279","phase":"","title":"Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-05-01","conditions":"Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive, Cancer Pain","enrollment":600},{"nctId":"NCT03222570","phase":"PHASE2","title":"An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2018-02-26","conditions":"Depressive Disorder","enrollment":90},{"nctId":"NCT05536414","phase":"PHASE2","title":"Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-09-12","conditions":"Major Depressive Disorder","enrollment":337},{"nctId":"NCT05470465","phase":"PHASE1","title":"Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2022-09-01","conditions":"Hypercapnia, Ventilatory Depression","enrollment":27},{"nctId":"NCT04973930","phase":"PHASE3","title":"Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2022-03-01","conditions":"Major Depressive Disorder, Breast Cancer, Venlafaxine","enrollment":20},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT04951609","phase":"PHASE1","title":"A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-02","conditions":"Depressive Disorder, Major","enrollment":31},{"nctId":"NCT03920410","phase":"NA","title":"Effect of Serotonergic Stimulation on the Gut-brain Axis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Örebro University, Sweden","startDate":"2019-04-24","conditions":"Healthy, Irritable Bowel Syndrome","enrollment":58},{"nctId":"NCT01778686","phase":"NA","title":"Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors","status":"COMPLETED","sponsor":"Gitte Moos Knudsen","startDate":"2013-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT04598230","phase":"PHASE3","title":"Partners in Caring for Anxious Youth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2021-02-09","conditions":"Anxiety, Separation, Anxiety, Generalized, Anxiety, Social","enrollment":468},{"nctId":"NCT02473250","phase":"PHASE4","title":"Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2015-01","conditions":"Bipolar Disorder","enrollment":40},{"nctId":"NCT02431845","phase":"NA","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Severance Hospital","startDate":"2013-01-01","conditions":"Obsessive-Compulsive Disorder","enrollment":200},{"nctId":"NCT03429075","phase":"PHASE2","title":"Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-01-07","conditions":"Depressive Disorder, Major","enrollment":59},{"nctId":"NCT04245748","phase":"PHASE4","title":"Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2020-03-01","conditions":"Anxious Depression, Depression","enrollment":84},{"nctId":"NCT04977232","phase":"NA","title":"Adjunctive Game Intervention for Anhedonia in MDD Patients","status":"COMPLETED","sponsor":"Central South University","startDate":"2021-09-09","conditions":"Depression","enrollment":50},{"nctId":"NCT06545474","phase":"NA","title":"Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2024-09-15","conditions":"Major Depressive Disorder","enrollment":106},{"nctId":"NCT05588102","phase":"NA","title":"Electronic Training of Elderly Depression With Cognitive Impairment","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-05-18","conditions":"Geriatric Depression, Cognitive Impairment","enrollment":128},{"nctId":"NCT05627154","phase":"NA","title":"Combined Antidepressant and Behavioural Intervention","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-05-28","conditions":"Low Mood, Depression, Anxiety","enrollment":134},{"nctId":"NCT02620150","phase":"PHASE4","title":"SSRI Effects on Depression and Immunity in HIV/AIDS","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-02-16","conditions":"Depression, HIV, AIDS","enrollment":108},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT04478526","phase":"NA","title":"Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions","status":"COMPLETED","sponsor":"Dr. Nazanin Alavi","startDate":"2020-04-29","conditions":"Generalized Anxiety Disorder","enrollment":115},{"nctId":"NCT06358014","phase":"NA","title":"Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen","status":"RECRUITING","sponsor":"Xiao Wang","startDate":"2023-05-12","conditions":"Postmenopausal Depression, Estrogen","enrollment":40},{"nctId":"NCT06153004","phase":"PHASE3","title":"OptimizeD Pilot Study","status":"COMPLETED","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2023-08-01","conditions":"Depression, Depressive Disorder","enrollment":76},{"nctId":"NCT06337539","phase":"","title":"Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants","status":"NOT_YET_RECRUITING","sponsor":"Germans Trias i Pujol Hospital","startDate":"2024-04-01","conditions":"Depression, Inflammation, Antidepressants","enrollment":50},{"nctId":"NCT01032083","phase":"PHASE4","title":"Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2011-07","conditions":"Schizophrenia","enrollment":62},{"nctId":"NCT03993535","phase":"PHASE4","title":"Predicting Treatment Response in Patients With OCD","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2018-10-10","conditions":"Obsessive-Compulsive Disorder","enrollment":250},{"nctId":"NCT05720637","phase":"NA","title":"The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder","status":"COMPLETED","sponsor":"Xiaomei Shao","startDate":"2022-11-01","conditions":"Major Depressive Disorder","enrollment":120},{"nctId":"NCT06212284","phase":"NA","title":"Serotonin, Anxiety and Visceral Sensation","status":"COMPLETED","sponsor":"University of Sussex","startDate":"2018-02-18","conditions":"Healthy","enrollment":31},{"nctId":"NCT04437485","phase":"PHASE2","title":"eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-10-14","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":46},{"nctId":"NCT02458690","phase":"PHASE2","title":"eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients","status":"COMPLETED","sponsor":"Indiana University","startDate":"2015-07","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":216},{"nctId":"NCT05952713","phase":"","title":"Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder","status":"COMPLETED","sponsor":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","startDate":"2022-10-01","conditions":"Major Depressive Disorder","enrollment":73336},{"nctId":"NCT05957094","phase":"NA","title":"Human Cerebral Blood Flow and Serotonin","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2023-08","conditions":"Depression, Serotonin Deficiency","enrollment":15},{"nctId":"NCT05850572","phase":"NA","title":"A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2023-07","conditions":"Depression","enrollment":100},{"nctId":"NCT03779789","phase":"PHASE4","title":"Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2019-02-01","conditions":"Major Depressive Disorder","enrollment":362},{"nctId":"NCT05832619","phase":"NA","title":"Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder","status":"UNKNOWN","sponsor":"Xiaomei Shao","startDate":"2022-11-01","conditions":"Major Depressive Disorder","enrollment":120},{"nctId":"NCT04748276","phase":"","title":"Tracking Response to Antidepressants in Advance of Investigational Trials","status":"UNKNOWN","sponsor":"Adams Clinical","startDate":"2019-01-02","conditions":"Major Depressive Disorder","enrollment":400},{"nctId":"NCT01742832","phase":"PHASE2","title":"Double-Blind Treatment of Major Depressive Disorder With Vilazodone","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2013-05","conditions":"Major Depressive Disorder","enrollment":79},{"nctId":"NCT05730062","phase":"PHASE1","title":"Influence of Oxycodone on Individuals Taking an SSRI","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-03-15","conditions":"Opioid Induced Respiratory Depression, Depressive Disorder, Anxiety Disorders","enrollment":55},{"nctId":"NCT02623205","phase":"PHASE4","title":"Advancing Personalized Antidepressant Treatment Using PET/MRI","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2015-05","conditions":"Depression","enrollment":85},{"nctId":"NCT05210140","phase":"","title":"Personalized Escitalopram Dosing in Patients With Depression","status":"UNKNOWN","sponsor":"University of Belgrade","startDate":"2020-07-16","conditions":"Depressive Disorder, Major","enrollment":148},{"nctId":"NCT02674529","phase":"PHASE2, PHASE3","title":"Study of Neural Responses Induced by Antidepressant Effects","status":"COMPLETED","sponsor":"Marta Peciña, MD PhD","startDate":"2016-09","conditions":"Major Depressive Disorder","enrollment":60},{"nctId":"NCT05605002","phase":"NA","title":"Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder","status":"UNKNOWN","sponsor":"Xiaomei Shao","startDate":"2022-01-01","conditions":"Major Depressive Disorder","enrollment":90},{"nctId":"NCT04069819","phase":"NA","title":"The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-08-01","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT02022709","phase":"PHASE4","title":"Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2014-01","conditions":"Obsessive-Compulsive Disorder, Anxiety Disorders, Mental Disorders","enrollment":78},{"nctId":"NCT05271084","phase":"PHASE1, PHASE2","title":"Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2021-11-10","conditions":"Major Depressive Disorder","enrollment":100},{"nctId":"NCT05346445","phase":"NA","title":"Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome","status":"COMPLETED","sponsor":"Hospital Regional 1o de Octubre","startDate":"2021-01-20","conditions":"Postmenopause, Hot Flashes","enrollment":91},{"nctId":"NCT03812588","phase":"PHASE4","title":"Contact: Developing New Clinical Management Strategies","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2019-01-30","conditions":"Major Depressive Disorder","enrollment":29},{"nctId":"NCT03346239","phase":"NA","title":"Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety","status":"COMPLETED","sponsor":"Tel Aviv University","startDate":"2018-07-20","conditions":"Social Anxiety Disorder","enrollment":105},{"nctId":"NCT05148169","phase":"PHASE4","title":"A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2020-01-01","conditions":"Major Depressive Disorder","enrollment":150},{"nctId":"NCT02579343","phase":"NA","title":"Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture","status":"COMPLETED","sponsor":"Florida Gulf Coast University","startDate":"2015-08","conditions":"Major Depressive Disorder","enrollment":13},{"nctId":"NCT05041582","phase":"PHASE3","title":"SSRIs and TDCS Enhance Post-stroke Motor Recovery","status":"UNKNOWN","sponsor":"Chih-Wei Tang","startDate":"2021-09-01","conditions":"Stroke, Motor","enrollment":80},{"nctId":"NCT04221256","phase":"PHASE1, PHASE2","title":"Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity","status":"WITHDRAWN","sponsor":"Burke Medical Research Institute","startDate":"2020-03-11","conditions":"Stroke, Ischemic","enrollment":""},{"nctId":"NCT02516332","phase":"NA","title":"Exercise and Pharmacotherapy for Anxiety in Cardiac Patients","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-12","conditions":"Anxiety, Cardiovascular Disease","enrollment":128},{"nctId":"NCT02092974","phase":"PHASE1","title":"Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2014-04","conditions":"Healthy Young and Older Adults","enrollment":40},{"nctId":"NCT02137369","phase":"PHASE4","title":"The ISLAND Study: InSuLa Assessed Needs for Depression","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-09","conditions":"Depression","enrollment":77},{"nctId":"NCT03464383","phase":"PHASE4","title":"Anxiety and Depression in Epilepsy: A Treatment Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-05-07","conditions":"Anxiety, Depression, Epilepsy","enrollment":69},{"nctId":"NCT02285699","phase":"NA","title":"The Gut Microbiota in Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"McMaster University","startDate":"2014-11-01","conditions":"Obsessive-Compulsive Disorder","enrollment":43},{"nctId":"NCT01931202","phase":"NA","title":"Mechanisms of Antidepressant Non-Response in Late-Life Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2014-02-19","conditions":"Major Depressive Disorder","enrollment":138},{"nctId":"NCT03554447","phase":"NA","title":"Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Mahmoud Samy Abdallah","startDate":"2015-04-20","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT03274817","phase":"PHASE1","title":"A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2009-06-18","conditions":"Alzheimer Disease","enrollment":5},{"nctId":"NCT02865642","phase":"PHASE2","title":"Cortical Ischemic Stroke and Serotonin","status":"UNKNOWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-08","conditions":"Stroke","enrollment":90},{"nctId":"NCT01041274","phase":"PHASE4","title":"DECIFER: Depression and Citalopram In First Episode Recovery","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2010-01","conditions":"Schizophrenia, Schizophreniform Disorder","enrollment":95},{"nctId":"NCT02825342","phase":"PHASE4","title":"PPI's and SSRI's Therapy for the Management of NCCP","status":"TERMINATED","sponsor":"Evangelismos Hospital","startDate":"2014-03","conditions":"Chest Pain Rule Out Myocardial Infarction","enrollment":60},{"nctId":"NCT02869035","phase":"PHASE1","title":"Treatment Outcome in Major Depressive Disorder","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2016-08","conditions":"Major Depressive Disorder","enrollment":100},{"nctId":"NCT03522987","phase":"PHASE4","title":"Anxiety and Depression in Epilepsy: A Pilot Treatment Study","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2018-05","conditions":"Anxiety, Depression, Epilepsy","enrollment":""},{"nctId":"NCT00642694","phase":"PHASE3","title":"Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-05","conditions":"Major Depressive Disorder, Insomnia","enrollment":29},{"nctId":"NCT01657760","phase":"PHASE1","title":"Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-05-01","conditions":"Alcohol Dependence","enrollment":31},{"nctId":"NCT01103180","phase":"PHASE2","title":"Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2010-09","conditions":"Borderline Personality Disorder","enrollment":70},{"nctId":"NCT02269540","phase":"EARLY_PHASE1","title":"A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2014-10","conditions":"Major Depressive Disorder","enrollment":10},{"nctId":"NCT00794040","phase":"PHASE2","title":"A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2008-11-17","conditions":"Mood Disorder, Mental Disorder Diagnosed in Childhood, Attention Deficit and Disruptive Behavior Disorder","enrollment":103},{"nctId":"NCT03927950","phase":"PHASE4","title":"Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment","status":"COMPLETED","sponsor":"University of Tartu","startDate":"2007-01","conditions":"Major Depression","enrollment":135},{"nctId":"NCT03607331","phase":"EARLY_PHASE1","title":"Auricular Concha Electro-acupuncture for the Treatment of Depression","status":"UNKNOWN","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2018-09-17","conditions":"Depression, Depressive Symptom, Depressive Disorder","enrollment":106},{"nctId":"NCT01788969","phase":"PHASE1","title":"Serotonergic Modulation of Motor Function in Subacute and Chronic SCI","status":"UNKNOWN","sponsor":"Shirley Ryan AbilityLab","startDate":"2005-06","conditions":"Spinal Cord Injury","enrollment":42},{"nctId":"NCT01753882","phase":"PHASE1","title":"Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)","status":"UNKNOWN","sponsor":"Shirley Ryan AbilityLab","startDate":"2012-02","conditions":"Spinal Cord Injury","enrollment":88},{"nctId":"NCT00456014","phase":"NA","title":"Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-09","conditions":"Depression","enrollment":37},{"nctId":"NCT02153567","phase":"PHASE3","title":"SSRI Study for Functional Dyspepsia (SS)","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2013-12-06","conditions":"Dyspepsia, Anxiety, Depression","enrollment":71},{"nctId":"NCT00787501","phase":"PHASE1","title":"Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2008-06","conditions":"Major Depressive Disorder","enrollment":98},{"nctId":"NCT03642405","phase":"","title":"Drug-induced Repolarization ECG Changes","status":"UNKNOWN","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2018-08-15","conditions":"Long QT Syndrome, ADHD, Depression","enrollment":150},{"nctId":"NCT03558256","phase":"NA","title":"The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2016-05-16","conditions":"Major Depressive Disorder","enrollment":105},{"nctId":"NCT02407821","phase":"PHASE2","title":"The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)","status":"TERMINATED","sponsor":"University Health Network, Toronto","startDate":"2015-03","conditions":"End Stage Renal Disease","enrollment":25},{"nctId":"NCT01903447","phase":"PHASE4","title":"Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2013-12-13","conditions":"Internalizing Psychopathologies (IPs) Depression and Anxiety","enrollment":271}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1758,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"citalopram (SSRI)","genericName":"citalopram (SSRI)","companyName":"Fundació Sant Joan de Déu","companyId":"fundaci-sant-joan-de-d-u","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Citalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain. Used for Major depressive disorder, Panic disorder, Obsessive-compulsive disorder (off-label).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}